×
About 2,585 results

ALLMedicine™ Kaposi Sarcoma Center

Research & Reviews  884 results

Skin conditions among pediatric dermatology outpatients in Botswana.
https://doi.org/10.1111/pde.15066
Pediatric Dermatology; Sethomo W, Williams VL et. al.

Jun 29th, 2022 - An understanding of the prevalence patterns of skin diseases in children in Botswana is needed to guide national dermatological policy development, training, and resource allocation to improve patient care. To describe local skin disease patterns ...

Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma
https://clinicaltrials.gov/ct2/show/NCT02659930

Jun 24th, 2022 - Background: Kaposi Sarcoma (KS) is a multicentric angioproliferative tumor that most frequently involves skin, but can also involve lymph nodes, lungs and gastrointestinal tract. It is most common in people with HIV or other forms of immune compro...

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
https://clinicaltrials.gov/ct2/show/NCT04941274

Jun 24th, 2022 - Background: Kaposi Sarcoma (KS) is a multicentric angioproliferative tumor, caused by Kaposi sarcoma-associated herpesvirus, that most frequently involves the skin, but may also involve lymph nodes, lungs, bone and gastrointestinal tract. It is mo...

Pomalidomide for Kaposi Sarcoma in People With or Without HIV
https://clinicaltrials.gov/ct2/show/NCT01495598

Jun 24th, 2022 - Background: Kaposi Sarcoma (KS) is an incurable, multicentric angioproliferative tumor that most frequently involves the skin. It is seen most frequently in people with HIV or other forms of immune compromise. Current therapies are limited by toxi...

Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
https://clinicaltrials.gov/ct2/show/NCT04902443

Jun 24th, 2022 - Background: There is an unmet need for less toxic and more effective treatments for virus-associated malignancies. Pomalidomide induces polyfunctional T cell, NK cell, and dendritic cell activation. Pomalidomide has shown promising activity in Kap...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  48 results

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
https://clinicaltrials.gov/ct2/show/NCT04941274

Jun 24th, 2022 - Background: Kaposi Sarcoma (KS) is a multicentric angioproliferative tumor, caused by Kaposi sarcoma-associated herpesvirus, that most frequently involves the skin, but may also involve lymph nodes, lungs, bone and gastrointestinal tract. It is mo...

Natural History of KSHV-Associated Multicentric Castleman s Disease
https://clinicaltrials.gov/ct2/show/NCT04968288

Jun 24th, 2022 - Background: Multicentric Castleman s disease (MCD) is a rare but lethal Kaposi s sarcoma-associated herpesvirus (KSHV) associated lymphoproliferative disorder with a historical median survival of 2 years. It occurs more often in HIV-infected indiv...

Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
https://clinicaltrials.gov/ct2/show/NCT04902443

Jun 24th, 2022 - Background: There is an unmet need for less toxic and more effective treatments for virus-associated malignancies. Pomalidomide induces polyfunctional T cell, NK cell, and dendritic cell activation. Pomalidomide has shown promising activity in Kap...

History of the KSHV Inflammatory Cytokine Syndrome (KICS)
https://clinicaltrials.gov/ct2/show/NCT01419561

Jun 24th, 2022 - BACKGROUND: KSHV inflammatory cytokine syndrome (KICS) is a newly recognized syndrome caused by Kaposi sarcoma-associated herpesvirus (KSHV). It is characterized by severe inflammatory symptoms including fevers, wasting, cytopenias, hypoalbuminemi...

NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
https://clinicaltrials.gov/ct2/show/NCT04303117

Jun 24th, 2022 - Background: Kaposi Sarcoma (KS) is a multicentric angioproliferative tumor, caused by Kaposi sarcoma-associated herpesvirus, that most frequently involves the skin, but may also involve lymph nodes, lungs, bone and gastrointestinal tract. It is mo...

see more →

News  95 results

Postirradiation Pseudosclerodermatous Panniculitis: A Rare Complication of Megavoltage External Beam Radiotherapy
https://www.mdedge.com/dermatology/article/255139/wounds/postirradiation-pseudosclerodermatous-panniculitis-rare
Peter W. Hashim, MD, MHS, Nikki S. Vyas, MD et. al.

Jun 2nd, 2022 - To the Editor: Postirradiation pseudosclerodermatous panniculitis (PIPP) is a rarely reported complication of megavoltage external beam radiotherapy that was first identified in 1993 by Winkelmann et al. 1 The condition presents as an erythematous.

Leiomyosarcoma of the Penis: A Case Report and Re-Appraisal
https://www.mdedge.com/fedprac/article/254639/oncology/leiomyosarcoma-penis-case-report-and-re-appraisal
Zainub Ajmal, MBBS, Abdul Moiz Khan, MBBS et. al.

May 16th, 2022 - Penile cancer is rare with a worldwide incidence of 0. 8 cases per 100,000 men.

Indurated Violaceous Lesions on the Face, Trunk, and Legs
https://www.mdedge.com/dermatology/article/251484/nonmelanoma-skin-cancer/indurated-violaceous-lesions-face-trunk-and-legs
Yasmin Khalfe, MD, John Trace Worrell, MD et. al.

Feb 4th, 2022 - The Diagnosis: Kaposi Sarcoma A punch biopsy of a lesion on the right side of the back revealed a diffuse, poorly circumscribed, spindle cell neoplasm of the papillary and reticular dermis with associated vascular and pseudovascular spaces distend.

Pembrolizumab/Lenvatinib Combo Under Investigation in Classic Kaposi Sarcoma
https://www.onclive.com/view/pembrolizumab-lenvatinib-combo-under-investigation-in-classic-kaposi-sarcoma

Nov 9th, 2021 - For patients with classic Kaposi sarcoma who relapse following their first or second line of chemotherapy, treatment options are extremely limited, according to Alice Indini, MD. In an effort to expand options available to this population, the pha...

Dr. Indini on the Rationale for the PULSAR Trial in Classic Kaposi Sarcoma
https://www.onclive.com/view/dr-indini-on-the-rationale-for-the-pulsar-trial-in-classic-kaposi-sarcoma

Sep 27th, 2021 - Alice Indini, MD, medical oncologist, Medical Oncology Unit, Department of Internal Medicine, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy, discusses the rationale for the phase 2 PULSAR trial in classic Kaposi sarcoma (...

see more →

Patient Education  5 results see all →